Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.

MLA

Fernandes, Gustavo Dos Santos, et al. “Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.” Journal of Gastrointestinal Cancer, vol. 49, no. 4, Dec. 2018, pp. 470–75. EBSCOhost, https://doi.org/10.1007/s12029-017-0001-3.

APA

Fernandes, G. D. S., Braghiroli, M. I., Artioli, M., Paterlini, A. C. C. R., Teixeira, M. C., Gumz, B. P., Girardi, D. da M., Braghiroli, O. F. M., Costa, F. P., & Hoff, P. M. (2018). Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients. Journal of Gastrointestinal Cancer, 49(4), 470–475. https://doi.org/10.1007/s12029-017-0001-3

Chicago

Fernandes, Gustavo Dos Santos, Maria Ignez Braghiroli, Michelle Artioli, Ana Carolina Carvalho Rocha Paterlini, Marcela Crosara Teixeira, Brenda Pires Gumz, Daniel da Motta Girardi, Oddone F M Braghiroli, Frederico Perego Costa, and Paulo M Hoff. 2018. “Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a Rechallenge Regimen for Heavily Pretreated Metastatic Colorectal Cancer Patients.” Journal of Gastrointestinal Cancer 49 (4): 470–75. doi:10.1007/s12029-017-0001-3.